Product
Peginterferon alfa-2b
Aliases
Peginterferon alfa-2b injection
6 clinical trials
8 indications
Indication
Chronic Hepatitis BIndication
MelanomaIndication
HIV/AIDSIndication
Hepatitis BIndication
Hepatocellular Carcinoma (HCC)Indication
Chronic Hepatitis B InfectionIndication
Hepatitis CIndication
ChronicClinical trial
A Multi-center, Randomized, Blinded Study to Evaluate the Efficacy and Safety of Peginterferon Alfa-2b Injection Combined With Tenofovir Disoproxil Fumarate Tablets in Patients With Chronic Hepatitis BStatus: Completed, Estimated PCD: 2023-11-30
Clinical trial
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk MelanomaStatus: Active (not recruiting), Estimated PCD: 2015-06-01
Clinical trial
A Clinical Research on Functional Cure Strategies for Hepatitis B Among HIV/HBV Co-infected Patients in ChinaStatus: Recruiting, Estimated PCD: 2026-08-02
Clinical trial
A Prospective, Randomized, Open-label, Multicenter Study to Evaluate the Peginterferon, Comparing to Nucleos(t)Ide Analogues, in Reducing the Incidence of HCC in Chronic Hepatitis B Patients With Intermediate to High Liver Cancer RisksStatus: Recruiting, Estimated PCD: 2023-08-01
Clinical trial
A Study on Antiviral Treatment of Chronic Hepatitis B in Children (Sprout Project)Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Randomized, Partially Double-Blind, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly With Pegylated-Interferon and Ribavirin in Treatment-Naive Patients With Chronic Genotype 2 or 3 Hepatitis C Virus InfectionStatus: Terminated, Estimated PCD: 2012-05-01